Status:
RECRUITING
Interventional Study to Improve Medication Adherence Using Patient Decision Aid
Lead Sponsor:
SingHealth Polyclinics
Conditions:
Hypothyroidism
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
Background: Although hypothyroidism is easily treated with levothyroxine (LT4) replacement, results from several studies indicate that people receiving LT4 replacement often have under- or over-repla...
Detailed Description
Patient decision aids (PDA) help people involved in decision making by providing information about the options and outcomes, and by clarifying their concerns. PDAs will help the patients to participat...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Age ≥21 years
- Able to read and speak English
- Active patient with hypothyroidism at SingHealth Polyclinics (SHP) {had minimum of 2 follow-up visits at the respective study site in the last 12 months}
- TSH \>3.70 milli-international units per liter (mIU/L)
- Exclusion Criteria:
- Euthyroid state (TSH 0.65-3.70 mIU/L)
- LT4 over-replacement (TSH \<0.65 mIU/L)
- Individuals who are severely ill or with hearing impairment and mental disturbances
- Pregnant women
- Sick euthyroid syndrome
Exclusion
Key Trial Info
Start Date :
March 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2025
Estimated Enrollment :
236 Patients enrolled
Trial Details
Trial ID
NCT06205303
Start Date
March 15 2024
End Date
September 30 2025
Last Update
May 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SingHealth Polyclinics
Singapore, Singapore